Alvotech (ALVO)
5.19
-0.13
(-2.44%)
USD |
NASDAQ |
Sep 08, 16:00
5.13
-0.06
(-1.16%)
After-Hours: 07:48
Alvotech Price : 5.19 for Sept. 8, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 08, 2026 | 5.26 | 5.32 | 5.142 | 5.19 | 632635.0 |
| Sep 04, 2026 | 5.31 | 5.40 | 5.205 | 5.32 | 535402.0 |
| Sep 03, 2026 | 5.37 | 5.47 | 5.275 | 5.38 | 673701.0 |
| Sep 02, 2026 | 5.24 | 5.415 | 5.171 | 5.34 | 700300.0 |
| Sep 01, 2026 | 5.08 | 5.265 | 4.98 | 5.24 | 1.029M |
| Aug 31, 2026 | 5.00 | 5.265 | 4.98 | 5.19 | 1.251M |
| Aug 28, 2026 | 4.84 | 5.00 | 4.82 | 4.95 | 878459.0 |
| Aug 27, 2026 | 4.88 | 4.979 | 4.785 | 4.88 | 967686.0 |
| Aug 26, 2026 | 4.98 | 4.99 | 4.782 | 4.91 | 890180.0 |
| Aug 25, 2026 | 5.24 | 5.39 | 5.015 | 5.05 | 1.772M |
| Aug 24, 2026 | 4.79 | 5.359 | 4.715 | 5.25 | 3.178M |
| Aug 21, 2026 | 4.32 | 4.595 | 4.32 | 4.43 | 2.269M |
| Aug 20, 2026 | 3.89 | 4.37 | 3.75 | 4.27 | 1.371M |
| Aug 19, 2026 | 4.00 | 4.08 | 3.94 | 3.99 | 546895.0 |
| Aug 18, 2026 | 3.92 | 4.00 | 3.83 | 3.95 | 675582.0 |
| Aug 17, 2026 | 4.04 | 4.04 | 3.77 | 3.88 | 591717.0 |
| Aug 14, 2026 | 4.15 | 4.185 | 3.985 | 4.055 | 607270.0 |
| Aug 13, 2026 | 3.98 | 4.14 | 3.84 | 4.09 | 559858.0 |
| Aug 12, 2026 | 3.81 | 4.02 | 3.76 | 4.01 | 921390.0 |
| Aug 11, 2026 | 3.77 | 3.86 | 3.75 | 3.80 | 772808.0 |
| Aug 10, 2026 | 3.81 | 3.85 | 3.685 | 3.77 | 1.023M |
| Aug 07, 2026 | 3.83 | 3.85 | 3.735 | 3.81 | 342031.0 |
| Aug 06, 2026 | 3.79 | 3.880 | 3.77 | 3.80 | 503349.0 |
| Aug 05, 2026 | 3.78 | 3.905 | 3.67 | 3.76 | 741941.0 |
| Aug 04, 2026 | 3.82 | 3.90 | 3.785 | 3.84 | 575289.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Teva Pharmaceutical Industries Ltd. | 36.76 |
| Agenus, Inc. | 7.43 |
| Amgen, Inc. | 393.17 |
| Anika Therapeutics, Inc. | 21.04 |
| BioCryst Pharmaceuticals, Inc. | 9.065 |
Price Related Metrics
| PS Ratio | 3.413 |
| Earnings Yield | -10.74% |
| Market Cap | 1.852B |
| Operating PE Ratio | 37.41 |